|Articles|October 1, 2003
Analysis Advances
Nashville, Tenn. - For the first time, molecular margin analysis has been performed in a timeframe suitable for intra-operative use during major head and neck squamous cell carcinoma resections, according to David Goldenberg, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement














